Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

8.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.6K
Paracrine Signaling01:21

Paracrine Signaling

59.7K
Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
59.7K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

111.6K
Overview
111.6K
Endocrine Signaling01:45

Endocrine Signaling

68.3K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.3K
Bacterial Signaling01:30

Bacterial Signaling

41.4K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
41.4K
Yeast Signaling01:28

Yeast Signaling

17.3K
Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
17.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The selective degradation of PDE4B shortform, using a PROTAC, leads to inhibition of several hallmarks of cancer in HCT116 cells.

British journal of pharmacology·2026
Same author

KTX207-mediated PDE4D degradation disrupts tumour cell migration, invasion, and angiogenic potential.

Cell communication and signaling : CCS·2026
Same author

Discovery of a PDE4B and PDE4D selective bifunctional degrader for management of chronic inflammatory disorders.

Journal of translational autoimmunity·2025
Same author

A connexin 43 targeting peptide prevents blood vessel neointima formation.

bioRxiv : the preprint server for biology·2025
Same author

Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in <i>TP53</i> wild-type and mutant cancer cells.

Molecular therapy. Oncology·2025
Same author

Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting.

The FEBS journal·2025
Same journal

The Finding of Posterior Wall Low-Voltage Zones During Cryoballoon Pulmonary Vein Isolation Facilitated by Periprocedural Electroanatomical Mapping Is Associated with a Worse Ablation Outcome.

Journal of cardiovascular development and disease·2026
Same journal

Autonomic Nervous Dysfunction and Ultra-Short-Term Heart Rate Variability in Atrial Fibrillation: Recent Advances in Early Detection.

Journal of cardiovascular development and disease·2026
Same journal

QRS-Corrected Prediction of the Diastolic Rest Period for Coronary CT Angiography in Patients with Complete Left Bundle Branch Block.

Journal of cardiovascular development and disease·2026
Same journal

Colchicine in Coronary Artery Disease-Too Much of a Good Thing?

Journal of cardiovascular development and disease·2026
Same journal

ANO1 (TMEM16A) Genetic Variants, Promoter Methylation, and Chloride Dysregulation in Pulmonary Hypertension.

Journal of cardiovascular development and disease·2026
Same journal

Prognostic Value of the Uric Acid-to-Albumin Ratio in Patients Undergoing Successful Percutaneous Coronary Intervention for Chronic Total Occlusion.

Journal of cardiovascular development and disease·2026
See all related articles

Related Experiment Video

Updated: Feb 15, 2026

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor
06:03

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor

Published on: March 22, 2024

1.7K

PDE4-Mediated cAMP Signalling.

Bracy A Fertig1, George S Baillie2

  • 1University of Glasgow, Glasgow G12 8QQ, UK. b.fertig.1@research.gla.ac.uk.

Journal of Cardiovascular Development and Disease
|February 1, 2018
PubMed
Summary
This summary is machine-generated.

Phosphodiesterase 4 (PDE4) enzymes compartmentalize cyclic AMP (cAMP) signaling in heart cells and blood vessels. PDE4 isoforms regulate crucial cardiovascular functions, offering therapeutic potential despite challenges with current inhibitors.

Keywords:
cardiac myocytephosphodiesterase 4vascular endothelium

More Related Videos

Mechanical Ventilation Boot Camp Curriculum
07:36

Mechanical Ventilation Boot Camp Curriculum

Published on: March 12, 2018

10.7K
Imaging G Protein-coupled Receptor-mediated Chemotaxis and its Signaling Events in Neutrophil-like HL60 Cells
08:24

Imaging G Protein-coupled Receptor-mediated Chemotaxis and its Signaling Events in Neutrophil-like HL60 Cells

Published on: September 14, 2016

10.6K

Related Experiment Videos

Last Updated: Feb 15, 2026

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor
06:03

Author Spotlight: Advancing Real-Time cAMP Detection in Cells Using cADDis Biosensor

Published on: March 22, 2024

1.7K
Mechanical Ventilation Boot Camp Curriculum
07:36

Mechanical Ventilation Boot Camp Curriculum

Published on: March 12, 2018

10.7K
Imaging G Protein-coupled Receptor-mediated Chemotaxis and its Signaling Events in Neutrophil-like HL60 Cells
08:24

Imaging G Protein-coupled Receptor-mediated Chemotaxis and its Signaling Events in Neutrophil-like HL60 Cells

Published on: September 14, 2016

10.6K

Area of Science:

  • Cardiovascular Cell Signaling
  • Molecular Pharmacology
  • Enzyme Function

Background:

  • Cyclic adenosine monophosphate (cAMP) is a vital second messenger in cardiovascular systems.
  • Phosphodiesterases (PDEs), particularly the PDE4 family, control cAMP levels by hydrolysis.
  • PDE4 enzymes are crucial for localized signaling in cardiac myocytes and vascular endothelium.

Purpose of the Study:

  • To review the critical roles of PDE4 isoforms in cardiovascular cell signaling.
  • To highlight PDE4's regulation of cardiac function and vascular barrier integrity.
  • To discuss the therapeutic potential and limitations of PDE4 inhibitors.

Main Methods:

  • Review of existing literature on PDE4 function in cardiovascular research.
  • Analysis of signalosome formation involving PDE4, cAMP effectors (PKA), and anchoring proteins (AKAPs).
  • Examination of PDE4 interactions with cardiac substrates and endothelial adherens junctions.

Main Results:

  • PDE4 isoforms orchestrate localized cAMP signaling essential for cardiac β-adrenergic responses.
  • PDE4 regulates cardiac excitation-contraction coupling through phosphorylation of specific substrates.
  • PDE4 controls vascular permeability and barrier function by interacting with adherens junctions.

Conclusions:

  • PDE4 isoforms play specific, non-redundant roles in cardiovascular physiology.
  • Targeting PDE4 offers significant therapeutic potential for cardiovascular diseases.
  • Current PDE inhibitors face challenges due to their broad activity against localized PDE4 signalosomes.